These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8678548

  • 1. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Hashimoto H, Tokumitsu M, Morikawa M, Numata A, Yachiku S, Iuchi H, Yamauchi K.
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
    [No Abstract] [Full Text] [Related]

  • 2. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Miura T, Murai T, Shimura H, Kondo I.
    Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
    [No Abstract] [Full Text] [Related]

  • 3. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T, Washizuka M, Kihara K, Takahashi T, Sakata Y, Tai K, Nagayama T, Okada K, Kusuyama H, Ishii Y.
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb 20; 22(1):40-6. PubMed ID: 3611890
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Intra-arterial infusion chemotherapy of advanced bladder cancer].
    Akiyama M, Inoue Y, Yokota K, Sumiyoshi Y.
    Gan To Kagaku Ryoho; 1992 Aug 20; 19(10 Suppl):1705-8. PubMed ID: 1530337
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb 20; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
    Gotoh A, Mizuno Y, Matsuwari S, Kitazawa S, Maeda S, Arakawa S, Kamidono S.
    Gan To Kagaku Ryoho; 1994 May 20; 21(6):899-902. PubMed ID: 8185353
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
    Yoshida K, Nakame Y, Horiuchi S, Kaneoya F, Kuroda T, Tanoiri A, Koizumi M, Takahashi M, Negishi T, Saitoh H.
    Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 1):1083-5. PubMed ID: 3083786
    [No Abstract] [Full Text] [Related]

  • 9. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
    Li Q, Xu X, Liu J.
    Zhonghua Zhong Liu Za Zhi; 1998 Jul 20; 20(4):308-9. PubMed ID: 10920993
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C.
    J Urol; 1997 Aug 20; 158(2):408-11. PubMed ID: 9224313
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T, Nakamura K, Uchiyama K, Tei Y, Aoki A, Naito K.
    Hinyokika Kiyo; 2006 Feb 20; 52(2):99-105. PubMed ID: 16541762
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy for advanced urothelial cancer.
    Yagoda A.
    Semin Urol; 1983 Feb 20; 1(1):60-74. PubMed ID: 6382528
    [No Abstract] [Full Text] [Related]

  • 13. [Intra-arterial chemotherapy for locally advanced bladder cancer].
    Aota Y, Yoshida K.
    Hinyokika Kiyo; 1999 Feb 20; 45(2):149-53. PubMed ID: 10212791
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
    Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS.
    J Urol; 2007 Jan 20; 177(1):84-9; discussion 89. PubMed ID: 17162009
    [Abstract] [Full Text] [Related]

  • 15. [The role of etoposide therapy in urogenital cancer].
    Kawai K, Akaza H.
    Gan To Kagaku Ryoho; 1996 Dec 20; 23(14):1929-35. PubMed ID: 8978800
    [Abstract] [Full Text] [Related]

  • 16. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
    Logothetis CJ, Samuels ML, Selig DE, Wallace S, Johnson DE.
    Cancer Treat Rep; 1985 Jan 20; 69(1):33-8. PubMed ID: 2981619
    [Abstract] [Full Text] [Related]

  • 17. [Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
    Hattori Y, Takizawa A, Kishida T, Kakizoe M, Fujikawa N, Teranishi J, Kondo K, Saito K, Noguchi K, Nakaigawa N, Kubota Y.
    Gan To Kagaku Ryoho; 2007 May 20; 34(5):739-43. PubMed ID: 17496448
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH, Chen J, Wu CY, Cheng AL, Pu YS.
    Anticancer Res; 2001 May 20; 21(1B):711-5. PubMed ID: 11299831
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy for metastatic bladder cancer; the EORTC experience.
    Stoter G.
    Prog Clin Biol Res; 1988 May 20; 260():471-9. PubMed ID: 3283767
    [No Abstract] [Full Text] [Related]

  • 20. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.
    Mulatero C, McClaren BR, Mason M, Oliver RT, Gallagher CJ.
    Br J Cancer; 2000 Dec 20; 83(12):1612-6. PubMed ID: 11104554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.